Inactive Instrument

Other languages Acer Therapeutics Inc.

Equities

ACER

US00444P1084

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Acer Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20
Chris Schelling Ceases to Be Chief Executive Officer of Acer Therapeutics Inc	11-20
Acer Therapeutics Inc. Announces Executive Changes	11-20
Zevra Therapeutics Completes Acer Acquisition	11-20
Zevra Therapeutics, Inc. completed the acquisition of Acer Therapeutics Inc. from funds affiliated with TVM Capital Life Science and others.	11-16
Top Midday Decliners	01/09/23
Sector Update: Health Care Stocks Lower in Late Afternoon Trading	31/08/23
Sector Update: Health Care	31/08/23
Top Midday Gainers	31/08/23
Zevra Therapeutics to Acquire Acer Therapeutics in Merger Deal	31/08/23
Relief Therapeutics Sells License for Urea Cycle Disorder Drug to Acer Therapeutics	31/08/23
Zevra Therapeutics, Inc. acquired Acer Therapeutics Inc. for $91.7 million.	30/08/23
Relief Therapeutics Holding AG Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics	30/08/23
Relief Therapeutics conclut un accord de licence avec Acer pour Olpruva	30/08/23
Relief Therapeutics schliesst Lizenz-Abkommen mit Acer für Olpruva	30/08/23
Acer Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2023	14/08/23
Acer Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Relief Therapeutics Partner Plans Commercial Launch of Rare Genetic Disease Drug by Mid-June	02/05/23
Relief-Partner Acer mit Fortschritten bei Vermarktung von Olpruva	01/05/23
Acer Therapeutics Inc. Provides an Update Indicating That the Commercial Launch Activities for OLPRUVA	01/05/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Acer Therapeutics Inc.

Equities

ACER

US00444P1084

Other languages

Filters